NCT03561779

Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee

A Randomized, Double-blind, Active-controlled, Multi-center, Phase 3 Study to Evaluated the Safety and Efficacy of Intraarticular Hyalurinic Acid(YYD302) for Osteoarthritis of the Knee After 12 Weeks of Treatment and Retreatment

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 184 (actual)
• Sponsor: Yooyoung Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, double-blind, active-controlled, multi-center, phase 3 study to evaluate the safety and efficacy of intraarticular hyaluronic acid(YYD302) for osteoarthritis of the knee after 12 weeks of treatment and retreatment

Detailed description

First Injection: A multicenter, active-controlled, randomized, evaluator and subject bllinded, parallel, phase 3 study Re-Injection: A multicenter, active-controlled, randomized, parallel

Conditions

• Osteoarthritis, Knee

Interventions

Type	Name	Description
DRUG	YYD302 2ml	YYD302 2ml
DRUG	Active comparator: Synovian Inj.	Active comparator: Synovian Inj.

Timeline

• Start date: 2018-02-21
• Primary completion: 2019-06-14
• Completion: 2019-10-04
• First posted: 2018-06-19
• Last updated: 2021-05-10

Locations

1 site across 1 country: South Korea